Prevention of cardiac disease in the elderly

Journal of Cardiovascular Risk

Volumn 8, Issue 5, 2001, Pages 271-277

  Gladdish, S ^a   Rajkumar, C ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Ageing; Blood pressure; Prevention; Risk factors; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; ATENOLOL; BENDROFLUMETHIAZIDE; CHLORTALIDONE; CHOLESTEROL; CLOPIDOGREL; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; METHYLDOPA; METOPROLOL; NITRENDIPINE; PERINDOPRIL; PINDOLOL; TRIAMTERENE;

AGED; AGING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETES MELLITUS; EXERCISE; HEART DISEASE; HUMAN; HYPERTENSION; INCIDENCE; MENOPAUSE; OBESITY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SMOKING;

AGED; DIABETES COMPLICATIONS; EXERCISE; FIBRINOGEN; GREAT BRITAIN; HEART DISEASES; HOMOCYSTEINE; HUMANS; HYPERTENSION; LIPIDS; OBESITY; RISK FACTORS; SMOKING CESSATION; VITAMIN E;

EID: 0034776699     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043798-200110000-00005     Document Type: Review

References (61)

1. Coronary heart disease statistics
2. Coronary heart disease statistics. Economic supplement
3. Cardiovascular risk factors in the elderly
4. Hypertension
5. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
6. Mortality and morbidity results from the European working party in high blood pressure in the elderly trial
7. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
8. Morbidity and mortality in the Swedish Trial of Old Patients with Hypertension (STOP-Hypertension)
9. Medical Research Council trial of treatment of hypertension in older adults
10. Morbidity and mortality in the placebo controlled European trial on isolated systolic hypertension in the elderly
11. The Australian therapeutic trial in mild hypertension
12. Randomized trial of treatment of hypertension in elderly patients in primary care
13. The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology, and comparison with previous trials
14. Double blind randomised trial of modest salt restriction in older people
15. Moderate potassium supplementation in essential hypertension
16. The INTERSALT Study: Relations of BMI to blood pressure
17. Alcohol consumption and blood pressure. Kaiser permanente multiphasic health examination data
18. Pressor effect of alcohol in hypertension
19. Physical fitness and blood pressure
20. Benefits of leisure-time physical activity on the cardiovascular risk profile at older age
21. Treatment of hypertension in the elderly
22. Lower patients' cholesterol now: Trial evidence showing clear benefits from secondary prevention
23. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
24. Lipoprotein lipids in older people
25. Ischaemic heart disease in the elderly
26. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
27. Cholesterol lowering therapy in women and elderly patients with myocardial infarction and angina
28. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS
29. Statins and blood pressure regulation
30. Diabetes in the elderly. A perspective from the United Kingdom
31. Risk factors for coronary artery disease in non-insulin dependant diabetes mellitus: United Kingdom prospective diabetes study (UKPDS 23)
32. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
33. The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin dependent diabetes mellitus
34. Mortality in older people with diabetes mellitus
35. Cigarette smoking, tar yields and non-fatal myocardial infarction: 14,000 Cases and 32,000 controls in the United Kingdom
36. Cigarette smoking among the elderly: Disease consequences and benefits of cessation
37. Prevention of coronary heart disease in clinical practice. Summary of Recommendations of the Second Joint Task Force of the European and other societies on coronary prevention
38. Body weight and mortality among women
39. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction in final report of the Lyon Diet Heart Study
40. Reduction in systolic arterial compliance is associated with left ventricular hypertrophy and diastolic dysfunction in older people
41. Hormone therapy to prevent disease and prolong life in postmenopausal women
42. An overview of randomised trials of rehabilitation with exercise after myocardial infarction
43. HRT in the over 65's
44. Mega-trials of hormone replacement therapy
45. Changes in physical activity, mortality, and incidence of coronary heart disease in older men
46. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study
47. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease and family history: The Scottish Heart Health Study
48. The HOPE Study. Ramipril lowered cardiovascular risk but vitamin E did not
49. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
50. Plasma level of homocysteine is correlated to extra-cranial carotid artery atherosclerosis in non-hypertensive Japanese
51. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976
52. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
53. Collaborative overview of randomised trials of anti-platelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged anti-platelet therapy in various categories of patients
54. ISIS-2 10-year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
55. A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events
56. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
57. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients
58. Beta blockade during and after myocardial infarction: An overview of the randomised trials
59. Longterm ACE inhibitor therapy in patients with heart failure or left ventricular dysfunction: A systematic overview of data from individual patients
60. Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: Results of prospectively designed overviews of randomised trials